MRI may be more trouble than it’s worth for diagnosing ACL tears

Athletes suffering suspected tears of the anterior cruciate ligament (ACL) are often adequately assessed with clinical diagnostic tests performed in the clinician’s office. When these are inconclusive, diagnostic arthroscopy is the gold standard—and MRI is a generally low-value option due to its time and cost burdens.

That’s according to a review of the literature published online Nov. 15 in the Journal of Sport Rehabilitation.

Accurately diagnosing or ruling out an ACL tear with palpations and observations of patients performing positional and range-of-motion movements involving the knee “could save the patient, patient’s family, employer or school money by avoiding an MRI,” write study authors Megan Brady, EdD, of Drake University in Des Moines and Windee Weiss, PhD, of the University of Northern Iowa.

The authors note the commonality of ACL injuries in athletes across competition levels from recreational to professional: around 200,000 per year.

They call for more research to test the accuracy of MRI vs. the movement tests, allowing that the latter’s sensitivity and specificity are largely dependent on the proficiency of the clinician.

Journal publisher Human Kinetics has posted the study in full for free (click “PDF”):

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Breast artery calcifications are already visible when radiologists review mammograms, but nothing typically happens with them. Researchers aimed to see if AI could help translate those findings into an easy-to-understand cardiovascular risk score.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.